Biomed Industries CEO To Chair Neurosciences 2025 And Present Breakthrough Research On Alzheimer's Disease And Obesity

(MENAFN - EIN Presswire)Biomed Industries, Inc- logoNA-831 for Alzheimer's DiseaseNA-931 for weight lossBiomed Industries, Inc. CEO to Chair NeuroSciences 2025 and Present Groundbreaking ...

featured-image

Biomed Industries, Inc- logo NA-831 for Alzheimer's Disease NA-931 for weight loss Biomed Industries, Inc. CEO to Chair NeuroSciences 2025 and Present Groundbreaking Research on Alzheimer's, Obesity, and Rett Syndrome Michael Willis Biomed Industries, Inc. +1 800-824-5135 email us here Visit us on social media: X LinkedIn Biomed introduction video Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind.

We do not accept any responsibility or liabilityfor the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in thisarticle. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN31032025003118003196ID1109373883 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind.



We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above..